Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Nine in 10 cancers caused by lifestyle
Up to nine in 10 cancers are caused by environmental and external factors such as smoking, drinking, sun exposure and air pollution, a new scientific study has found.
Amgen: European Commission has approved the use of IMLYGIC™
PR Newswire – THOUSAND OAKS, Calif.
Certain Antidepressants Linked to Bipolar Mania
Taking certain antidepressants for depression is linked to a greater risk of subsequent mania and a new diagnosis of bipolar disorder, according to a new study published in the online journal BMJ Open...
GSK receives positive top-line results from sirukumab phase III programme supporting regulatory filings for rheumatoid arthritis in 2016
GlaxoSmithKline plc (LSE/NYSE.
Array BioPharma reports top-line results from binimetinib Phase 3 trial in patients with NRAS-mutant melanoma
Array BioPharma (Nasdaq.
China watchdog to strengthen drug trial inspections
China's drug regulator said on Thursday it will strengthen oversight of clinical trials of new drugs, where it said regulation was falling short despite a recent push to improve the quality of loc...
Martin Shkreli arrested by FBI over hedge fund investigation
Pharmaceuticals entrepreneur held in investigation into his time at MSMB Capital Management and at Retrophin.
FDA Approves Basaglar® (insulin glargine injection), a Long-Acting Insulin Treatment
INDIANAPOLIS and RIDGEFIELD, Conn.
Nurofen maker Reckitt Benckiser defends Australia packaging
The UK maker of the Nurofen "specific pain" range of products has defended their packaging, after an Australian court ordered the products off shelves.
FDA Approves Bridion (sugammadex) to Reverse Effects of Neuromuscular Blocking Drugs
December 15, 2015 -- The U.
Scientists identify a molecular key that helps maintain identity and prevents the conversion of adult cells into iPS cells
By Hannah L.
Novo Nordisk Files for Regulatory Approval of Faster-Acting Insulin Aspart in the US for the Treatment of Type 1 and 2 Diabetes
Novo Nordisk announced the submission of the New Drug Application (NDA) for faster-acting insulin aspart to the US Food and Drug Administration (FDA).
635
636
637
638
639
640
641
642
643
